VOR — Vor Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $116.65m
- -$20.53m
- 13
- 38
- 23
- 14
Annual cashflow statement for Vor Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.8 | -43.3 | -68.9 | -92.1 | -118 |
| Depreciation | |||||
| Non-Cash Items | 0.748 | 2.12 | 7.33 | 17.1 | 13.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.145 | 4.32 | -9.01 | -12.7 | 0.65 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.86 | -36.3 | -69.1 | -85.1 | -100 |
| Capital Expenditures | -0.748 | -4.16 | -3.89 | -8.46 | -1.07 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -87.8 | -85.6 | 72.1 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.748 | -4.16 | -91.7 | -94.1 | 71 |
| Financing Cash Flow Items | — | — | -2.21 | 0 | -0.717 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17.7 | 82.5 | 233 | 117 | 2.94 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.1 | 42.1 | 72.1 | -62.1 | -26.3 |